Insight Molecular Diagnostics Inc. also files under OCX; those filings are included.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | Last Andrew J. | Director | Tax withholding(F) | 8K | $5.69 | $44K |
| Jul 1, 2026 | Arno Andrew | Director | Tax withholding(F) | 12K | $5.69 | $69K |
| Jul 1, 2026 | Silverman Lou | Director | Tax withholding(F) | 8K | $5.69 | $44K |
| Jun 11, 2026 | Arno Andrew | Director | Grant(A) | 32K | — | $0 |
| Jun 11, 2026 | Silverman Lou | Director | Grant(A) | 27K | — | $0 |
| Jun 11, 2026 | Last Andrew J. | Director | Grant(A) | 27K | — | $0 |
| Apr 27, 2026 | Broadwood Partners, L.P. | 10% Owner | Buy(P) | 251K | $3.64 | $913K |
| Apr 27, 2026 | Broadwood Partners, L.P. | 10% Owner | Buy(P) | 0 | — | $0 |
| Apr 24, 2026 | Broadwood Partners, L.P. | 10% Owner | Buy(P) | 39K | $3.53 | $137K |
| Apr 24, 2026 | Broadwood Partners, L.P. | 10% Owner | Buy(P) | 0 | — | $0 |
| Apr 23, 2026 | Broadwood Partners, L.P. | 10% Owner | Buy(P) | 280K | $3.50 | $982K |
| Apr 23, 2026 | Broadwood Partners, L.P. | 10% Owner | Buy(P) | 0 | — | $0 |
| Apr 20, 2026 | Broadwood Partners, L.P. | 10% Owner | Buy(P) | 41K | $3.88 | $158K |
| Apr 20, 2026 | Broadwood Partners, L.P. | 10% Owner | Buy(P) | 0 | — | $0 |
| Apr 17, 2026 | Broadwood Partners, L.P. | 10% Owner | Buy(P) | 0 | — | $0 |
| Apr 17, 2026 | Broadwood Partners, L.P. | 10% Owner | Buy(P) | 40K | $3.57 | $143K |
| Apr 16, 2026 | Broadwood Partners, L.P. | 10% Owner | Buy(P) | 0 | — | $0 |
| Apr 16, 2026 | Broadwood Partners, L.P. | 10% Owner | Buy(P) | 102K | $3.45 | $352K |
| Mar 26, 2026 | Liu James Yang | VP ACCT, Cntlr, Treasurer, PAO | Option exercise(M) | 6K | — | — |
| Mar 26, 2026 | Riggs Josh | CEO and President, Director | Option exercise(M) | 47K | — | — |
| Mar 26, 2026 | James Andrea S. | Chief Financial Officer | Option exercise(M) | 28K | — | $0 |
| Mar 26, 2026 | Liu James Yang | VP ACCT, Cntlr, Treasurer, PAO | Tax withholding(F) | 3K | $4.11 | $11K |
| Mar 26, 2026 | James Andrea S. | Chief Financial Officer | Tax withholding(F) | 11K | $4.11 | $46K |
| Mar 26, 2026 | James Andrea S. | Chief Financial Officer | Option exercise(M) | 28K | — | — |
| Mar 26, 2026 | Riggs Josh | CEO and President, Director | Tax withholding(F) | 12K | $4.11 | $51K |
| Mar 26, 2026 | Riggs Josh | CEO and President, Director | Option exercise(M) | 47K | — | $0 |
| Mar 26, 2026 | Liu James Yang | VP ACCT, Cntlr, Treasurer, PAO | Option exercise(M) | 6K | — | $0 |
| Feb 10, 2026 | Bradsher Neal C | 10% Owner | Buy(P) | 0 | — | $0 |
| Feb 10, 2026 | Bradsher Neal C | 10% Owner | Buy(P) | 522K | $5.75 | $3.0M |
| Oct 31, 2025 | James Andrea S. | Chief Financial Officer | Option exercise(M) | 50K | — | $0 |
| Oct 31, 2025 | James Andrea S. | Chief Financial Officer | Option exercise(M) | 50K | — | $0 |
| Oct 31, 2025 | James Andrea S. | Chief Financial Officer | Tax withholding(F) | 12K | $6.01 | $73K |
| Sep 28, 2025 | Liu James Yang | VP ACCT, Cntlr, Treasurer, PAO | Grant(A) | 18K | — | $0 |
| Sep 28, 2025 | James Andrea S. | Chief Financial Officer | Grant(A) | 235K | — | $0 |
| Sep 28, 2025 | Riggs Josh | CEO and President, Director | Grant(A) | 400K | — | $0 |
| Jul 1, 2025 | Silverman Lou | Director | Grant(A) | 35K | — | $0 |
| Jul 1, 2025 | Last Andrew J. | Director | Grant(A) | 35K | — | $0 |
| Jul 1, 2025 | Arno Andrew | Director | Grant(A) | 55K | — | $0 |
| Mar 26, 2025 | James Andrea S. | Chief Financial Officer | Grant(A) | 113K | — | $0 |
| Mar 26, 2025 | Liu James Yang | VP ACCT, Cntlr, Treasurer, PAO | Grant(A) | 10K | — | $0 |
| Mar 26, 2025 | Liu James Yang | VP ACCT, Cntlr, Treasurer, PAO | Grant(A) | 19K | — | $0 |
| Mar 26, 2025 | Riggs Josh | CEO and President | Grant(A) | 189K | — | $0 |
| Feb 7, 2025 | Smith Patrick W | 10% Owner | Other(J) | 386K | $2.05 | $791K |
| Feb 7, 2025 | James Andrea S. | Chief Financial Officer | Buy(P) | 98K | $2.05 | $200K |
| Feb 7, 2025 | Smith Patrick W | 10% Owner | Buy(P) | 1.1M | $2.05 | $2.2M |
| Feb 6, 2025 | Broadwood Partners, L.P. | 10% Owner | Buy(P) | 4.5M | $2.05 | $9.2M |
| Feb 6, 2025 | Broadwood Partners, L.P. | 10% Owner | Buy(P) | 0 | — | $0 |
| Feb 6, 2025 | Broadwood Partners, L.P. | 10% Owner | Buy(P) | 660K | $2.05 | $1.4M |
| Feb 6, 2025 | Broadwood Partners, L.P. | 10% Owner | Buy(P) | 0 | — | $0 |
| Feb 4, 2025 | Smith Patrick W | 10% Owner | Buy(P) | 25 | $2.02 | $51 |
| Jan 31, 2025 | Smith Patrick W | 10% Owner | Buy(P) | 890 | $2.01 | $2K |
| Jan 30, 2025 | Smith Patrick W | 10% Owner | Buy(P) | 318 | $2.01 | $639 |
| Jan 29, 2025 | Smith Patrick W | 10% Owner | Buy(P) | 4K | $2.01 | $8K |
| Jan 14, 2025 | Smith Patrick W | 10% Owner | Buy(P) | 10K | $2.15 | $22K |
| Jan 14, 2025 | Smith Patrick W | 10% Owner | Buy(P) | 100 | $2.08 | $208 |
| Jan 13, 2025 | Smith Patrick W | 10% Owner | Buy(P) | 6K | $2.08 | $12K |
| Dec 26, 2024 | Smith Patrick W | 10% Owner | Buy(P) | 90K | $2.13 | $192K |
| Dec 26, 2024 | Arno Andrew | Director | Buy(P) | 13K | $2.11 | $26K |
| Dec 5, 2024 | James Andrea S. | Chief Financial Officer | Buy(P) | 20K | $2.29 | $46K |
| Oct 11, 2024 | James Andrea S. | Chief Financial Officer | Grant(A) | 100K | — | $0 |
| Oct 11, 2024 | James Andrea S. | Chief Financial Officer | Grant(A) | 200K | — | $0 |
| Oct 2, 2024 | Broadwood Capital Inc | 10% Owner | Buy(P) | 0 | — | $0 |
| Oct 2, 2024 | James Andrea S. | Chief Financial Officer | Buy(P) | 34K | $2.97 | $100K |
| Oct 2, 2024 | Broadwood Capital Inc | 10% Owner | Buy(P) | 1.3M | $2.95 | $3.9M |
| Jul 1, 2024 | Arno Andrew | Director | Grant(A) | 30K | — | $0 |
| Jul 1, 2024 | Last Andrew J. | Director | Grant(A) | 30K | — | $0 |
| Jul 1, 2024 | Silverman Lou | Director | Grant(A) | 30K | — | $0 |
| Jun 20, 2024 | James Andrea S. | Chief Financial Officer | Grant(A) | 200K | — | $0 |
| Jun 20, 2024 | James Andrea S. | Chief Financial Officer | Grant(A) | 100K | — | $0 |
| May 20, 2024 | Liu James Yang | Sr Dir., Cntlr, PAO, Int PFO | Grant(A) | 10K | — | $0 |
| May 20, 2024 | Riggs Josh | CEO and President, Director | Grant(A) | 90K | — | $0 |
| May 20, 2024 | Arno Andrew | Director | Grant(A) | 20K | — | $0 |
| Apr 15, 2024 | Broadwood Partners, L.P. | 10% Owner | Other(J) | 0 | — | — |
| Apr 15, 2024 | Broadwood Partners, L.P. | 10% Owner | Other(J) | 3K | — | — |
| Apr 11, 2024 | Riggs Josh | CEO and President, Director | Buy(P) | 3K | $2.95 | $10K |
| Apr 11, 2024 | Arno Andrew | Director | Buy(P) | 34K | $2.95 | $100K |
| Apr 11, 2024 | Broadwood Partners, L.P. | 10% Owner | Buy(P) | 0 | — | $0 |
| Apr 11, 2024 | Broadwood Partners, L.P. | 10% Owner | Buy(P) | 2.4M | $2.92 | $7.1M |
| Oct 10, 2023 | Liu James Yang | Sr Dir Controller PAO Int PFO | Grant(A) | 8K | — | $0 |
| Aug 15, 2023 | Riggs Josh | CEO and President, Director | Grant(A) | 40K | — | $0 |
| Jun 30, 2023 | Gutfreund John Peter | Insider | Other(J) | 3.6M | — | $0 |
| Jun 30, 2023 | Gutfreund John Peter | Insider | Other(J) | 3.1M | — | $0 |
| Jun 23, 2023 | Last Andrew J. | Director | Grant(A) | 90K | — | $0 |
| Jun 23, 2023 | Last Andrew J. | Director | Grant(A) | 20K | — | $0 |
| Jun 23, 2023 | Arno Andrew | Director | Grant(A) | 135K | — | $0 |
| Jun 23, 2023 | Arno Andrew | Director | Grant(A) | 30K | — | $0 |
| Jun 23, 2023 | Kingsley Alfred D | Director | Grant(A) | 90K | — | $0 |
| Jun 23, 2023 | Kingsley Alfred D | Director | Grant(A) | 20K | — | $0 |
| Jun 23, 2023 | Silverman Lou | Director | Grant(A) | 113K | — | $0 |
| Jun 23, 2023 | Silverman Lou | Director | Grant(A) | 25K | — | $0 |
| Jun 14, 2023 | Kingsley Alfred D | Director | Buy(P) | 30K | $0.21 | $6K |
| Jun 9, 2023 | Riggs Josh | CEO and President, Director | Grant(A) | 800K | — | $0 |
| Jun 9, 2023 | Riggs Josh | CEO and President, Director | Grant(A) | 350K | — | $0 |
| Apr 5, 2023 | Pura Vida Investments, LLC | 10% Owner | Buy(P) | 663K | $0.30 | $199K |
| Apr 3, 2023 | Gutfreund John Peter | Director | Disposed to issuer(D) | 588 | — | $0 |
| Apr 3, 2023 | Gutfreund John Peter | Director | Grant(A) | 705K | $0.35 | $247K |
| Apr 3, 2023 | Gutfreund John Peter | Director | Grant(A) | 1.0M | $0.35 | $350K |
| Apr 3, 2023 | Arno Andrew | Director | Grant(A) | 141K | $0.35 | $49K |
| Apr 3, 2023 | Arno Andrew | Director | Grant(A) | 141K | $0.35 | $49K |
| Apr 3, 2023 | Arno Andrew | Director | Grant(A) | 141K | $0.35 | $49K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Insight Molecular Diagnostics Inc., SEC CIK 0001642380. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under IMDX and shows every filing by that issuer (also filed as OCX).
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for IMDX